Clinical Trials Browser

Uterine Cervical Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Neoplasms, Germ Cell and Embryonal

Esophageal Neoplasms

Carcinoma, Non-Small-Cell Lung

Esophageal Squamous Cell Carcinoma

Locally Advanced Cervical Cancer

Gallbladder Neoplasms

Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer

Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement, Breast Neoplasms

Urinary Bladder Neoplasms

Nasopharyngeal Carcinoma

Carcinoma, Uterine Cervical Neoplasms

Endometrial Neoplasms

EGFR Positive Non-small Cell Lung Cancer

Breast Neoplasms

Head and Neck Neoplasms

Carcinoma, Non-Small-Cell Lung

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Esophageal Squamous Cell Carcinoma

Esophageal Neoplasms

Gallbladder Neoplasms

Esophageal Neoplasms

Neoplasms, Germ Cell and Embryonal

Gastro-enteropancreatic neuroendocrine tumor

Esophageal Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Oesophagogastric Cancer

Uterine Cervical Neoplasms

Adenocarcinoma of Lung

Lung Neoplasms

Uterine Cervical Neoplasms

Nasopharyngeal Carcinoma

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Small Cell Lung Carcinoma

Lung Neoplasms

Uterine Cervical Neoplasms

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Nasopharyngeal Carcinoma, Carcinoma, Squamous Cell, Nasopharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Nasopharyngeal Carcinoma, Carcinoma, Squamous Cell, Nasopharyngeal Neoplasms

Neoplasm Metastasis, Stomach Neoplasms

Mesothelioma, Malignant

Esophageal Neoplasms, Neoplasms, Squamous Cell

Clinical Trials

NELCER

FOCUS / KOV-04

DACT-GCT

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

LEDANG

A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma

MICHELE

POLCAGB

ACCESS-I

PATHOS

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.

Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

REVO

Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma

Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma

TIP

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

SCOPE2

Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer

ST03

CERVIPIB

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

TAXIS01

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

Customizing

Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)

Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III

CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy

Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients

Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)

Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC

A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus